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Abstract
Background: While several mouse strains have recently been developed for tracing neural crest or
oligodendrocyte lineages, each strain has inherent limitations. The connection between human SOX10 mutations
and neural crest cell pathogenesis led us to focus on the Sox10 gene, which is critical for neural crest
development. We generated Sox10-Venus BAC transgenic mice to monitor Sox10 expression in both normal
development and in pathological processes.
Results: Tissue fluorescence distinguished neural crest progeny cells and oligodendrocytes in the Sox10-Venus
mouse embryo. Immunohistochemical analysis confirmed that Venus expression was restricted to cells expressing
endogenous Sox10. Time-lapse imaging of various tissues in Sox10-Venus mice demonstrated that Venus
expression could be visualized at the single-cell level in vivo due to the intense, focused Venus fluorescence. In the
adult Sox10-Venus mouse, several types of mature and immature oligodendrocytes along with Schwann cells were
clearly labeled with Venus, both before and after spinal cord injury.
Conclusions: In the newly-developed Sox10-Venus transgenic mouse, Venus fluorescence faithfully mirrors
endogenous Sox10 expression and allows for in vivo imaging of live cells at the single-cell level. This Sox10-Venus
mouse will thus be a useful tool for studying neural crest cells or oligodendrocytes, both in development and in
pathological processes.
Background
The neural crest (NC) is a transient embryonic tissue.
NC cells delaminate from the dorsal neural tube as it
closes [1] and migrate to distinct locations, where they
differentiate into various cell types, including neurons,
glia, melanocytes, endocrine cells, and mesenchymal
cells [2-5].
The Sox proteins belong to the HMG (high mobility
group) domain of transcription factors [6,7]. Sox-E is
the earliest marker of a subset of cells at the border of
the neural plate that will give rise to NC-lineage cells
[8]. Sox10, which is a member of the Sox-E family and
shares high sequence homology with other Sox-E
member transcription factors, regulates and coordinates
diverse developmental processes such as organ develop-
ment and cell survival and specification. Sox10 is highly
expressed in the emerging NC and later in the develop-
ing glial cells of the peripheral nervous system (PNS)
and central nervous system (CNS) [9,10]. Whether in
mice or humans, Sox family protein deletions or muta-
tions often result in developmental defects and congeni-
tal disease, and mutations of the human SOX10 gene
are associated with NC cell abnormalities [9,11-13].
Several transgenic mouse strains dedicated to tracing
the NC lineage have already been developed, such as
Wnt1-Cre [14], Protein zero (P0)-Cre [15], and Ht-PA-
Cre [16] mice crossed with Cre-dependent reporter
mice. The Cre recombinase expression was previously
visualized by LacZ,ab-galactosidase reporter gene
inserted in the ROSA26 locus, that is expressed only
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any medium, provided the original work is properly cited.after the loxP-flanked intervening sequence is excised by
C r e[ 1 7 ] .O n c eas p e c i f i cp r o m o ter is activated, the cell
is indelibly tagged with b-galactosidase. This kind of
transgenic mouse is useful for monitoring the transient
activation of various promoters, including the NC-
specific promoter. Recently, mouse strains expressing a
fluorescence-based reporter upon Cre-mediated condi-
tional gene deletion have been developed for prospective
cell sorting or direct observation without fixation [18];
the CAG-CAT-EGFP reporter transgenic mouse strain
expresses enhanced green fluorescent protein (EGFP)
when the loxP-flanked CAT gene located between the
modified chicken b-actin promoter (CAG promoter)
and the EGFP gene [18] is excised with Cre. In previous
studies, we have used mice that enable Cre/loxP-
mediated cell labeling with LacZ or EGFP to analyze the
NC lineage and to trace NC cells after their migration
and differentiation [5,19-21].
However, for specific gene regulation analysis, trans-
genic or knock-in mouse lines that express a specific
gene profile in vivo are more useful, because the repor-
ter gene is expressed only while the specific promoter
or enhancer is active, and ceases when the promoter
becomes inactive. Reporter mice have recently been
developed to evaluate cell-type specification and matura-
tion in the oligodendroglial lineage; these are the
2’-3’-cyclic nucleotide 3’-phosphodiesterase (CNP)-EGFP
and myelin proteolipid protein (PLP)-EGFP transgenic
mouse lines [22,23]. The CNP-EGFP transgenic mouse,
in which the CNP promoter controls EGFP expression,
has been used for the prospective identification of live
oligodendroglial cells both in vivo and in vitro [23]. The
PLP-EGFP transgenic mouse, in which EGFP expression
is driven by the mouse PLP gene promoter, has also
been developed for investigating oligodendrocyte lineage
cells without fixation and immunostaining [22].
Sox10 expression is closely related to NC-lineage cells.
The Sox10
LacZ/+ [24], Sox10-rtTA [25], and Sox10-Cre
[26] mouse lines have all been reported to label NC cells
and oligodendrocytes. Sox10
LacZ/+ [24], a mutant mouse
targeting Sox10, was generated by replacing the open
reading frame of Sox10 with lacZ sequences. The Sox10-
LacZ/+ mutation causes haploinsufficiency, in which even
heterozygous pups have the phenotype found in mice
with a spontaneous mutation in the Sox10 allele.
Although LacZ expression in this knock-in strain faith-
fully reflects the endogenous Sox10 expression, it is diffi-
cult to observe normal developmental behavior in the
labeled cells because of the abnormal and pathological
condition of the Sox10
LacZ/LacZ homozygous mice [24].
Another unique reporter strain is the Sox10-rtTA knock-
in mouse [25], in which a variant of the reverse tetracy-
cline-controlled transactivator (rtTA) is inserted into the
genomic Sox10 locus, and the mice are crossed with the
doxycycline-dependent LacZ reporter line. This strain
correctly recapitulates endogenous Sox10 expression in
the NC and its derivatives, and also in oligodendrocytes.
This inducible transgenic system is limited in its range of
analysis, because the reporter gene expression is tempor-
ary and requires X-gal staining [25]. The Sox10-Cre
transgenic mouse strain, designated as the S4F:Cre
mouse, when crossed with the reporter line strain Rosa-
LacZ, identifies cells expressing Sox10, including
NC-derived cells, oligodendrocytes, and cells in the ven-
tral neural tube [26]. These strains are powerful tools for
tracing the progeny of Sox10-expressing cells in analyses
of NC cell migration and oligodendroglial differentiation.
However, permanent reporter gene expression does not
permit the real-time analysis of Sox10 expression. To
overcome these limitations, we generated a new Sox10-
Venus transgenic mouse, and confirmed that it enables
the normal behavior of Sox10-expressing cells to be
observed in vivo.
Results
Sox10-Venus BAC transgenic mouse generation
To examine the Sox10 expression profile in vivo,w e
took advantage of the bacterial artificial chromosome
(BAC) transgenic strategy where entire regulatory
machinery for a given gene expression might be covered
with a single BAC clone. In short, we modified a 225.6
kb-sized BAC clone RP24-85O14 by means of homolo-
gous recombination to harbor the coding sequence of
the fluorescent Venus protein [27] in-frame to the
Sox10 translation initiation codon (ATG) that locates at
the middle portion of the clone. This construct yielded
seven BAC transgenic founders expressing Venus and
we hereafter analyzed the complete expression profile in
ap a r t i c u l a rt r a n s g e n i cf ounder with the brightest
illumination.
First, we evaluated the distribution of Venus fluores-
cence at each developmental stage of the Sox10-Venus
mouse embryo. Venus fluorescence in classical NC lineage
tissues was directly visible from outside the embryo by
using an epifluorescence microscope and a UV light. At
embryonic day 11.5 (E11.5 d), Venus green fluorescence
was particularly intense in the dorsal root ganglia (DRG)
and the trigeminal ganglia (cranial nerve V) (Figure 1A).
We observed that Venus fluorescence was not limited to
classical NC lineage tissue, but was also observed in non-
NC tissues, including the otic ve s i c l e .T h i si sc o n s i s t e n t
with previous studies in which in situ hybridization
revealed endogenous Sox10 expression in otic vesicle cells
[28,29], which are the primitive state of the vestibuloco-
chlear nucleus (cranial nerve VIII). In the facial area of the
E11.5 d embryo, aggregated green cells were observed
among scattered Venus-positive cells (Figure 1B). The
intensity and resolution of the Venus fluorescence allowed
Shibata et al. Molecular Brain 2010, 3:31
http://www.molecularbrain.com/content/3/1/31
Page 2 of 14us to observe single cells in a pattern suggestive of the NC
cell rostral migration process (arrowheads in Figure 1B).
As development proceeded from E11.5 d to E15.5 d,
Venus fluorescence from the DRGs and nuclei of the cra-
nial nerves located in deep tissues gradually decreased,
due to the thickening dermal layer (Figure 1A, C, and
Additional file 1A - 1C). However, migrating Venus
+ cells
in the superficial layer of the embryonic skin were now
detectable from outside the body. Venus fluorescence was
observed in the Schwann cells of the neural network stem-
ming from the spinal nerve’s posterior branches, and in
peripheral sensory nerve fibers (Figure 1D). In the hind
limb, the peripheral nerve network and the adjacent vascu-
lar network were visible (Figure 1E). Three-dimensional
reconstructions of the peripheral nerve fibers displayed
the entire neural network in the craniofacial area, which
Figure 1 The novel Sox10-Venus transgenic mouse strain.T h eSox10-Venus BAC transgenic mouse strain was generated to investigate the
Sox10 expression profile in vivo. (A) Venus could be detected in NC lineage tissues, including the DRG and trigeminal ganglia, in E11.5 d mice.
Sox10
+ cells that were not NC-derived, including cells in the otic vesicle, could also be visualized with Venus. (B) High-intensity fluorescence
enabled us to observe a migration stream at the single-cell level, from outside the embryo. (C) At E15.5 d, deep-tissue Venus fluorescence
decreased. At this age, migrating Venus
+ cells and the network formation of Venus
+ cells in the superficial skin layer could be traced. (D) The
posterior branches of the spinal nerve were clearly visualized with Venus
+ Schwann cells, along with peripheral nerve fibers. (E) In the hind limb,
the peripheral nerve and vascular network formations were clearly outlined. (F) The peripheral neural network mainly derived from cranial nerve
VII could be visualized with three-dimensional reconstruction with an Olympus MVX-CSU microscope. (G) Time-lapse imaging of the front facial
area of embryonic Sox10-Venus mice clearly showed individual Venus
+ cell movement (also shown in movies in Additional Files 2 and 3). (B) and
(D, E) are high-magnification images of the indicated areas in Figures (A) and (C), respectively. Cranial nerves V, trigeminal nerve; VII, facial nerve;
VIII, vestibulocochlear nerve, Scale bars; (A-F) 1.0 mm.
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(cranial nerve VII) (Figure 1F).
Observing the behavior of individual Sox10-Venus cells
The intensity and resolution of the Venus fluorescence
in the new Sox10-Venus mice led us to evaluate whether
it was possible to monitor the behavior of individual
cells. Time-lapse imaging ex-vivo in skin explants from
E14.5 d Sox10-Venus embryos was first performed using
an epifluorescence microscope. Within this experimental
setup, it was easy to detect and follow the movements
of single cells (Figure 1G and the movie in Additional
File 2). As Sox10 is expressed in deep tissues during the
early stages of development, we next examined whether
it would be possible to observe Venus fluorescence in
whole Sox10-Venus embryos. Whole embryos at E10.5 d
were observed using a confocal microscope, and fol-
lowed over time. Time-lapse imaging of the front facial
area allowed us to monitor the migration of several
Venus
+ cells within the embryo over a duration of sev-
eral hours. We were also able to observe the shape
dynamics of individual migrating cells (movie in Addi-
tional File 3).
Venus fluorescence in frozen sections of
Sox10-Venus mice
To confirm the Venus
+ cell distribution, we prepared
cryosections of Sox10-Venus mice from each embryonic
stage and observed the Venus fluorescence directly, with-
out any antibody staining or enhancement procedure
Figure 2 Venus expression in neural crest lineage tissues and in otic vesicle observed without immunostaining. The distribution
of Venus
+ cells in Sox10-Venus mice was evaluated in embryonic-stage cryosections. Venus fluorescence was directly observed without
immunostaining. (A) On the thoracic region of an E15.5 d axial section, Venus
+ cells were localized to the DRG and its central and peripheral
branches. In the spinal cord, Venus
+ cells were broadly localized to both the gray matter and the white matter. Venus
+ sympathetic ganglion
cells were also found at the ventral side of the vertebral body (arrows). (B) In an E15.5 d horizontal section of the cranial area, Venus
+ cells
concentrated and formed the trigeminal ganglia (the nucleus of the V cranial nerve) and its first branch, the ocular nerve, also visualized by
Venus. (C) Venus
+ cells were randomly localized in the E15.5 d adrenal gland. (D) NC-derived enteric ganglion cells were seen originating from
the XII cranial nerve (Nervous Vargus) and migrating in an oral to anal direction in the alimentary tract. (D-E) On the lumbar level axial section,
Venus
+ cells were captured in the esophagus, stomach, midgut, and hindgut in the stream of their migration. (F-G) The primary structure of the
inner ear, designated as the otic vesicle, also expresses Venus in the embryonic period. The otic vesicle is not NC-derived, but expresses Sox10.
SC, spinal cord; TG, trigeminal ganglia; AG, adrenal gland; Es, esophagus; St, stomach; Hg, hindgut; Mg, midgut; Ov, otic vesicle. Scale bars
(A-C, E) 100 μm, (D, F-G) 50 μm.
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E15.5 d mouse embryos, Venus fluorescence was intense
in the DRG and its proximal and peripheral branches
(Figure 2A). Venus
+ cells were diffusely present through-
out the spinal cord. Some ganglion cells were positive for
Venus (Figure 2A, arrows) in the sympathetic ganglia
located at the ventral side of the vertebral disc. In hor-
izontal cranial sections from E15.5 d Sox10-Venus
embryos, large numbers of Venus
+ cells accumulated
to form the trigeminal ganglia (cranial nerve V) (Figure
2B). Venus was highly expressed in the ocular nerve,
w h i c hi st h ef i r s tb r a n c ho ft h et r i g e m i n a ln e r v e .
Venus
+ cells were randomly distributed in the E15.5 d
adrenal gland, most likely due to the incomplete col-
umn structure formation at this stage (Figure 2C). In
the alimentary tract, Venus
+ enteric ganglion cells ori-
ginating from the vagal nerve (cranial nerve XII) were
found migrating in a rostrocaudal direction through
the esophagus, stomach, midgut, and hindgut (Figure
2D and 2E). All of these tissues are well-known NC
derivatives, demonstrating that the Venus fluorescence
observed in the Sox10-Venus mice is consistent with
known NC cell localization and differentiation [1-3,5].
I nt h eo t i cv e s i c l e ,w h i c hi st h ep r i m a r ys t r u c t u r eo f
the inner ear nerve, cells continuously expressed Venus
throughout the embryonic period (Figure 2F and 2G).
The otic vesicle is not a NC derivative, but Sox10 pro-
tein expression in otic vesicle cells during the embryo-
nic stage has been reported [28,29].
Cell type evaluation of the Venus
+ cells in
Sox10-Venus mice
To verify that the Venus expression correctly reflects the
endogenous expression of the Sox10 protein in vivo,w e
performed immunohistochemistry of E11.5 d to postna-
tal 1-week-old (P1 w) whole mouse frozen sections.
Without exception, in all the tissues and stages exam-
ined, all the Sox10-positive cells expressed Venus. In
addition to Sox10 immunostaining, we also examined
cell-type-specific markers in NC-derived and Sox10
+ tis-
sues. The enteric ganglion cells in the alimentary tract
stained with PGP9.5 antibodies. In the esophagus, sto-
mach, midgut, and hindgut, most of the migrated
enteric ganglion cells were positive for Venus at E15.5 d
(Figure 3A). In the E15.5 d adrenal gland stained for tyr-
osine hydroxylase (TH), a marker for catecholaminergic
cells, TH-positive endocrine cells were positive for
Venus (Figure 3B). In the early embryonic (E11.5 d)
DRG, all Hu-positive sensory neurons were co-labeled
with Sox10 and Venus (Figure 3C). These observations
confirmed that Sox10-Venus is a useful reporter strain,
in which Venus expression faithfully reflects the endo-
genous Sox10 in vivo expression.
Loss of Venus-fluorescence correlates with the shutdown
of endogenous Sox10 expression
To evaluate the on/off switching of reporter gene activity
in Sox10-Venus mice, we verified the Sox10 expression
with immunohistochemistry, and examined its correlation
with Venus fluorescence. At the late embryonic stage of
E15.5 d, the loss of Sox10 expression in Hu-positive DRG
neurons coincided with a dramatic decrease in Venus
fluorescence, compared to the early embryonic stage
(Figure 3C and 3D). A similar phenomenon was observed
in embryonic sympathetic ganglia: most of the TH
+ neu-
rons were Venus
+ in the early embryonic stage, while TH
+
neurons in the late embryonic stage lost both Venus and
Sox10 expression (Figure 3E and 3F).
The prompt on/off switching of reporter gene activ-
ity is an important characteristic of this transgenic
mouse strain. In mice in which the NC lineage is
labeled, such as the Wnt1-Cre/CAG-CAT-EGFP dou-
ble transgenic mouse, NC progeny expressing Cre are
indelibly labeled with the reporter gene. At the late
embryonic stage of E15.5 d, neurons in the DRG and
sympathetic ganglia of Wnt1-Cre/CAG-CAT-EGFP
mice were still labeled with EGFP fluorescence even
though endogenous Sox10 expression had already
diminished (Additional file 4). In contrast, the sensitive
on-off switching of the Venus-fluorescent reporting
makes the Sox10-Venus mouse an accurate, real-time
reporter strain.
Identification of Venus
+ cells in the intact embryonic
spinal cord
Previous reports have suggested that Sox10 is expressed
in oligodendrocyte progenitor cells (OPCs) and mature
oligodendrocytes [24-26]. We examined the identity of
the Venus
+ cells observed in the ventral region of the
intact embryonic spinal cord of Sox10-Venus mice by
immunohistochemistry. The Venus
+ cells were negative
for the pan-neuronal marker Hu (Figure 4A), but posi-
tive for the oligodendroglial-lineage markers GSTπ and
Olig2 (Figure 4B and 4C). Therefore, in the spinal cord
of the embryonic Sox10-Venus mouse, Venus labels oli-
godendroglial-lineage cells without distinction as to
their degree of maturation.
Venus
+ cells in the intact and injured spinal cords of
adult Sox10-Venus mice
To examine the phenotype of Venus
+ cells in intact and
injured spinal cords of Sox10-Venus mice, we first observed
changes in the Venus
+ cells over time (Figure 5A - C).
After spinal cord injury (SCI), there was a sharp drop in
the number of Venus
+ cells, followed by a gradual accumu-
lation around the lesion epicenter at later stages after the
injury.
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Page 5 of 14Figure 3 Venus expression faithfully reflects endogenous Sox10 expression. Immunohistochemistry was used to confirm the in vivo co-
localization of Venus with specific cell-type markers in Sox10-Venus mice. (A-F) All Sox10-positive cells were also positive for Venus; no ectopic
Venus expression was detected in an entire series of sections. (A) In the E15.5 d alimentary tract, PGP9.5-positive enteric ganglion cells were also
positive for Venus. (B) TH-positive endocrine cells in the E15.5 d adrenal gland were invariably positive for Venus. (C-D) While all Hu-positive early
embryonic DRG neurons expressed endogenous Sox10 and Venus protein at E11.5 d, mature DRG neurons lost the Sox10 and Venus expression
simultaneously at E15.5 d, and Sox10
+ satellite cells became positive for Venus. (E-F) In the embryonic sympathetic ganglia, all the TH
+ neurons
were also Venus
+ at E11.5 d, whereas TH
+/Venus
- cells appeared at E15.5 d. Hu
+, terminally differentiated neuron; PGP9.5
+, enteric ganglion cell;
TH
+, adrenal gland endocrine cells and sympathetic ganglion neurons; epi, epithelium. Scale bars (A-F) 50 μm.
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+ cells in the intact embryonic spinal cord. Immunohistochemical analysis of Venus
+ cells in the intact embryonic
spinal cord of Sox10-Venus mice. (A) Venus fluorescence did not colocalize with the pan-neuronal marker Hu in the ventral area of Sox10-Venus
mice. (B-C) These Venus
+ cells expressed the oligodendroglial lineage markers GSTπ and Olig2, showing that the Venus
+ cells were OPCs and
mature oligodendrocytes. Scale bars; (A-C) 50 μm.
Figure 5 Sox10-Venus
+ cells actively accumulate at the spinal cord injury site. Venus fluorescence illuminated the behavior of Sox10-
expressing cells after a spinal cord injury. (A) In an intact adult mouse spinal cord, Venus
+ cells were clearly visible in both in the gray and the
white matter. (B) In the acute phase of contusive spinal cord injury (4 dpi; days-post-injury), Venus
+ cells were absent from the lesion site. (C) In the
subacute phase (14 dpi), numerous Venus
+ cells were present around the lesion and delineated the lesion epicenter. Scale bars (A-C) 500 μm.
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+ cells in intact and
injured spinal cords by immunostaining with various cell
markers (Figure 6A - H). In the intact spinal cord, Venus
+
cells were easily visualized in both the gray and white
matter (Figure 5A), and were mostly positive for GSTπ
(Figure 6A). After contusive SCI, Sox10-expressing cells
disappeared from the lesion epicenter (Figure 5B). In the
acute phase of SCI (4 days-post-injury; 4 dpi), cells posi-
tive for NG2 and Venus appeared in the residual white
matter (Figure 6B). Although NG2 is also known to stain
reactive astrocytes and macrophages [30], the Venus
+
c e l l so b s e r v e di nt h ei n j u r e ds p i n a lc o r dw e r en e g a t i v e
for GFAP (Figure 6D) and CD11b (Figure 6E), indicating
that they were Sox10-expressing oligodendrocytes. We
also observed Venus
+ cells that were positive for
PDGFRa, an OPC marker (Figure 6C), suggesting that
OPCs also expressed Sox10 in the injured spinal cord.
In the later subacute phase of SCI (14 dpi), numerous
Venus
+ cells were found in the epicenter and around
the lesion site (Figure 5C). Immunohistochemistry
revealed that many of the Venus
+ cells were positive for
S100b, a marker of the Schwann cell lineage, confirming
Schwann cell involvement after SCI (Figure 6F). Some
of the Venus
+ cells had bipolar processes and were posi-
tive for p75, suggesting that they were immature
Schwann cells (Figure 6G), while a few Venus
+ mature
Schwann cells were also identified by their P0 expres-
sion (Figure 6H). The observation that both immature
and mature Schwann cells were Venus
+ in the injured
spinal cord is consistent with the Schwann cell lineage
deriving from the NC.
Comparison of the Sox10-Venus strain with other NC
reporter mouse strains
The data from several NC reporter mouse lines, such as
Sox10(S4F)-Cre, P0-Cre, Wnt1-Cre, and Ht-Pa-Cre
[5,14,16,26,31,32], have already been published. To com-
pare this body of data to the observations gained from
the Sox10-Venus mouse, the embryonic expression pat-
terns of various NC-derived tissues are summarized for
each strain in Table 1. At the early embryonic period
(E11.5 d - E12.5 d), the reporter gene activity of all the
mouse strains was quite similar. All the strains demon-
strated reporter gene activity in numerous NC-lineage
tissues, including the DRG, sympathetic ganglia, melano-
blasts, enteric nervous system, superior/jugular ganglion,
aorta, and craniofacial mesenchyme. All the strains also
showed reporter expression in the otic vesicle, which
does not originate from the NC.
Regarding the differences in these reporter strains, CNS
myelinating glial cells were not labeled in the P0-Cre,
Wnt1-Cre, and Ht-Pa-Cre strains; they were only labeled
in the Sox10-related strains Sox10-Venus and Sox10
(S4F)-Cre. In the brain and spinal cord, the labeling of
oligodendroglial cells and OPCs in the Sox10-Venus and
Sox10-Cre mice reflected the endogenous Sox10 expres-
sion in these cells, since they are not derived from the
NC. The peripheral nerve network in developing limbs
consists of nerve fibers and their associated Schwann
cells, which are both derived from the NC. Although the
LacZ expression in the developing limb was ambiguous
in the Sox10(S4F)-Cre/Rosa-LacZ mouse [26], the Venus
fluorescence observed in the same region with the Sox10-
Venus mouse clearly originated from the Schwann cells
(Figure 1E).
Discussion
In this study, we developed and characterized the Sox10-
Venus BAC transgenic mouse. Analysis of the early
embryonic stages showed that not only NC lineage cells,
but also oligodendroglial cells were clearly labeled with
high-intensity Venus fluorescence (Figure 1 and 2).
Compared to other published transgenic and knock-in
reporter mouse strains, the Sox10-Venus mouse has
advantages that make it invaluable for future studies.
The mice with NC-lineage tracing Wnt1-Cre, P0-Cre,
and Ht-PA-Cre, crossed with those with Cre/loxP-
mediated cell labeling, Rosa-LacZ and CAG-CAT-EGFP,
can be used only for analyzing cell lineage or migration,
because the target cells are irreversibly labeled [5,14-20].
Although Sox10-Venus also labels NC-lineage cells, the
fast on/off switching of Venus fluorescence is tightly
correlated with endogenous Sox10 expression. Similarly,
the reporter gene activity in CNP-EGFP and PLP-EGFP
mice, which are transgenic mice that label oligodendro-
glial-lineage cells, truly reflects the in vivo expression of
specific genes driven by specific promoters or enhancers.
The transgenic system of the Sox10-Venus mouse is
quite similar to these; however, the Venus fluorescence
is brighter and more intense than EGFP fluorescence.
Although reporter gene activity occurs in NC cells and
oligodendrocytes in all Sox10 reporter mouse lines, i.e.,
Sox10
LacZ/+, Sox10-rtTA, Sox10-Cre strains [24-26], and
the new Sox10-Venus strain, each line has advantages
and disadvantages. LacZ knock-in Sox10
LacZ/+ heterozy-
gous pups are prone to spontaneous mutation pheno-
types due to haploinsufficiency. Also, to observing the
LacZ expression in Sox10
LacZ/+ mice requires additional
visualization procedures, making live cell imaging diffi-
cult. The Sox10-rtTA knock-in crossed with the induci-
ble TRE-LacZ transgenic is unique, but the reporter
expression is transient and does not fluoresce, making it
difficult to observe directly. The Sox10-Cre/CAG-CAT-
EGFP double transgenic mouse traces both NC and oli-
godendrocyte progeny, since it reports past as well as
ongoing Sox10 expression. With this double transgenic
mouse, it is possible to carry out cell sorting or live
imaging.
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Page 8 of 14Figure 6 Immunohistochemical analysis of Sox10-Venus
+ cells after spinal cord injury.( A - E )O P C sa n dm a t u r eo l i g o d e n d r o c y t e sw e r e
Venus
+ in the intact and injured spinal cord of Sox10-Venus mice. (A) Most Venus
+ cells were positive for GSTπ in the intact spinal cord. (B) In
the acute phase (4 dpi), NG2
+ cells increased in the residual white matter in response to the SCI. Some of the NG2
+ cells also expressed Venus.
(C-E) In the acute phase, Venus
+ oligodendroglial cells were also positive for PDGFRa (C), but were negative for GFAP (D) and CD11b (E). (F) In
the subacute phase of the SCI (14 dpi), S100b
+ cells were also present around the lesion site, and expressed Venus. (G) Some of the Venus
+ cells
were positive for p75, suggesting that they were immature Schwann cells with bipolar processes. (H) A small number of Venus
+ cells were
mature Schwann cells, as assessed by Protein Zero expression. Scale bars; (A-E) 20 μm, (F-H) 50 μm.
Shibata et al. Molecular Brain 2010, 3:31
http://www.molecularbrain.com/content/3/1/31
Page 9 of 14The Sox10-Venus strain overcomes most of the disad-
vantages of the above-mentioned Sox10 reporter mouse
lines. In this mouse, the intense Venus fluorescence can
be directly observed from outside the embryo, without
staining or enhancement procedures (Figure 1, 2, and
movies in Additional Files 2 and 3). Venus expression
faithfully reflects real-time endogenous Sox10 expression,
with prompt on/off switching (Figure 3). Although the
choice of strain obviously depends on the purpose of the
study, we believe that the Sox10-Venus mouse is the most
appropriate reporter line for numerous fields of research.
Although in vivo time-lapse imaging of oligodendro-
glial cell migration (including OPCs) has recently been
reported, it has only been conducted in zebrafish
[33,34]. Accurate time-lapse imaging has been difficult
to conduct in mice until now. There are several issues
that need to be considered in such studies. For instance,
(1) Is the normal and natural behavior of the cells or
tissues of interest being observed? In some cases, the
invasive procedures required to complete the imaging,
including surgical incision, tissue-slice culture, electro-
poration, dye injection, and virus infection, may affect
the tissues observed. (2) To what degree does the trans-
genic manipulation affect the phenotype? In Sox10
LacZ/+
mice, the resulting phenotype, coupled with haploinsuf-
ficiency, complicates analysis of the area of interest. Our
analysis of the Sox10-Venus transgenic line demon-
strates that it has neither developmental defects nor
ectopic Venus expression. Thus, the Sox10-Venus strain
appears to be a useful tool for investigating normal
developmental processes via live cell monitoring, using
directly observed fluorescence without invasive interven-
tion procedures (Figure 1G, movies in Additional Files 2
and 3).
Sox10 is a well-known marker of neural crest stem cells
(NCSCs), along with slug, snail,a n dp75 [35,36]. There
have been numerous reports recently of NCSCs surviving
in a wide range of tissues through the entire lifespan of
the animal, suggesting that NCSCs may have the poten-
tial to support the regeneration and recovery of damaged
tissues. The Venus fluorescence in Sox10-Venus mice
will make it possible to prospectively sort Venus
+ cells by
flow-cytometry and collect an enriched population of
NCSCs. Since NCSCs are located in easily accessible per-
ipheral tissues such as the skin and bone marrow, NCSCs
have been receiving increasing attention for future clini-
cal applications in cell transplantation therapy, because
the feasibility of autologous transplantation is anticipated
[37-39]. Autologous cell transplantation therapy avoids
the immunological and ethical concerns related to the
use of embryonic stem cells. We hope that the Sox10-
V e n u ss t r a i nw i l lp r o v et ob eap o w e r f u lt o o lf o re n h a n -
cing the progress of NCSC research.
The mouse is an excellent model system for studying
human disease progression and pathogenesis. We demo-
nstrated the usefulness of our new reporter mouse strain
Sox10-Venus for monitoring processes occurring after a
traumatic disorder (Figure 5 and 6), and crossing it with
mutant mouse lines may provide insight into the pro-
cesses behind numerous developmental defects. As with
the analysis conducted in CNP-EGFP mice to study the
behavior of oligodendroglial cells in SCI [30], Sox10-
Venus mice have potential applications not only for
oligodendrocyte research, but also for all Sox10
+-tissue
analyses, including disorders of the NC cells and periph-
eral nerves. The ability to visualize the processes of dis-
ease initiation and progression will help to shed light on
the pathophysiology of many human diseases.
Table 1 Comparison of reporter expression in Sox10-Venus and various other mice with NC lineage-labeling
Tissues Sox10-Venus Sox10-Cre P0-Cre Wnt1-Cre Ht-Pa-Cre
Dorsal root ganglia + + + + +
Sympathetic ganglia + + + + +
Melanoblasts + + + + +
Enteric nervous system + + + + +
Superior/jugular ganglion + + + + +
Aortae + + + + +
Craniofacial mesenchyme + + + + +
Otic vessicle + + + + +
Oligodendroglia + + - - -
Ventral neural tube + + - - -
Developing limb + + - - -
Reporter gene expression patterns at the embryonic stage are compared in various mice developed to trace neural crest derivatives: Sox10-Venus, Sox10(S4F)-Cre
[26], P0-Cre [5,15], Wnt1-Cre [14,16,26,31,32], and Ht-Pa-Cre [16,26]. All these lines have similar labeling patterns in both NC-lineage tissues (DRG, sympathetic
ganglia, melanoblasts, enteric nervous system, superior/jugular ganglion, aorta, craniofacial mesenchyme) and in tissues not in the NC lineage (otic vesicle,
oligodendroglial cells, and OPCs). In the developing limbs of Sox10-Venus and Sox10-Cre mice, which reflect the endogenous Sox10 expression profile, the
reporter fluorescence clearly labeled oligodendroglial cells and the peripheral nervous network. Immunohistochemistry did not detect any ectopic reporter gene
expression in any tissues from the embryonic Sox10-Venus mice.
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We developed the novel Sox10-Venus BAC transgenic
mouse line, in which Venus fluorescence labels NC and
oligodendroglial lineage cells. Endogenous Sox10 expres-
sion is accurately reported by Venus fluorescence over
the course of normal development, without ectopic
Venus expression. The highly intense reporter fluores-
cence allows for in vivo imaging of single-cell migration.
This strain will be especially useful for analyzing spinal
cord injury and studying NCSCs.
Methods
BAC Construction and development of Sox10-venus
BAC transgenic mice
For generating the Sox10-Venus transgenic mouse, we
prepared the following BAC construction. Detailed proce-
dures will be described elsewhere (CA, TI, YUI, manu-
script in preparation). Briefly, a BAC clone RP24-85O14
(CHORI, BACPAC Resources) that covers 225.6 kb terri-
tory of mouse Sox10 gene locus was electroporated into
the recombinogenic bacterial strain EL250 for systematic
modifications [40]. To obtain in-frame replacement of the
exon containing the Sox10 translation initiation codon
(ATG) to the Venus-polyadenylation signal (pA) cassette
in the BAC clone, 1.2 kb homology arms were amplified
by PCR and sequentially subcloned into the pBluescriptII
vector (Stratagene). Then the Venus-pA-FRT-Kanamycin-
resistant gene (Kan
r)-FRT cassette was inserted in between
the arms and the fragment containing the Venus-pA-Kan
r
cassette with the homology arms was isolated by agarose
gel electrophoresis for homologous recombination which
was processed in EL250 as was reported previously [41].
Precise insertion of the Venus-pA cassette and excision of
the Kan
r in the Sox10-BAC was verified by PCR as well as
pulse field gel electrophoresis and the modified BAC clone
was linearlized by PI-SceI, dialyzed and diluted to ~2 ng/μl
for pronuclear injections as previously described [41]. For
BAC transgenic mouse founders, presence of RP24 BAC
vector sequences immediately upstream or downstream of
the PI-SceI site was always examined by PCR tail DNA
analyses to minimize the possibility that fortuitous dele-
tions occur on the BAC transgene after the chromosomal
integrations [41]. The established BAC transgenic mouse
lines were bred with wild-type C57BL/6J mice and the tail
DNA was used for the PCR genotyping: The PCR primers
for the transgene detections are provided in Table S1;
Additional File 5.
Animals
We purchased wild-type C57BL/6J and ICR mice from
SLC Japan. The Cre-expressing transgenic lines, Wnt1-
Cre [14] and P0-Cre [15], were mated with an
EGFP reporter line (CAG-CAT-EGFP [18]) to obtain
Wnt1-Cre/CAG-CAT-EGFP and P0-Cre/CAG-CAT-
EGFP double-transgenic mice. All mice were housed
under specific pathogen-free conditions. All experimen-
tal procedures were approved by the Institutional Ani-
mal Care and Use Committee of Keio University,
Murayama Medical Center, and Tokyo Medical and
Dental University. All surgical interventions and animal
care procedures were in accordance with the Laboratory
Animal Welfare Act, the Guide for the Care and Use of
Laboratory Animals (National Institute of Health, USA).
Histological analysis
Immunohistochemical analyses were performed as
described previously [5,42,43]. Briefly, E9.5 d, n = 3;
E10.5 d, n = 10; E11.5 d, n = 9; E12.5 d, n = 5; E13.5 d, n
= 6; E14.5 d, n = 3; E15.5 d, n = 7; E16.5 d, n = 3; P0 d, n
= 3; and P1 w, n = 3 transgenic embryos (E0 = day of
plug) and pups were fixed with 4% PFA, and 16-μm-thick
cryosections were prepared with the cryostat CM3000
(Leica). The detailed information about the primary
and secondary antibodies was described in Table S1;
Additional File 5. Antigen retrieval was applied for speci-
fic targets (anti-Olig2, anti-hSox10) by incubating them
w i t hT a r g e tR e t r i e v a lS o l u t i o n( D a k o )i na na u t o c l a v ea t
105°C for 5 minutes. Fluorescence immunostaining with
specific primary antibodies was performed overnight at 4°
C, followed by one-hour incubation at room temperature
with the appropriate secondary antibodies conjugated
with Alexa488, Alexa555, or Alexa647 (Invitrogen) along
with Hoechst 33258 (10 μg/ml, Sigma) for nuclear stain-
ing. The samples were examined with a laser scanning
confocal microscope (LSM700 or Pascal: Carl Zeiss) or
fluorescent microscope (BZ-9000: Keyence, MVX-CSU:
Olympus).
Time-Lapse Imaging
Time-lapse observation (Figure 1G, movies in Addi-
tional Files 2 and 3) was performed as described pre-
viously [44,45]. Briefly, freshly isolated embryos were
collected in cold phosphate buffered saline (PBS) and
genotyped based on their Venus fluorescence, using an
inverted epifluorecence microscope (Leica MZ10F).
The embryos were transferred with 100 - 150 µl of
enriched medium to the center of a 35-mm glass-bot-
tom dish (hole size 27 mm; Matsunami) and mixed
with 100-150 µl of type I collagen-gel solution
(Cellmatrix IA; Nitta Gelatin). The solution had been
previously diluted to 0.5-0.6 mg/ml with distilled
water, 5× DMEM, and a neutralizing buffer, with a
final concentration about 0.3 mg/ml, according to the
manufacturer’s protocol. The gel was incubated at 37°
C for 20 minutes. Once the gel was solidified, up to
600 μl of imaging culture medium was gently added to
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was as follows: DMEM/F-12 (1:1), glucose (0.6%),
L-glutamine (2 mM), sodium bicarbonate (3 mM),
HEPES buffer (50 mM), insulin (25 μg/ml), transferrin
(100 μg/ml), progesterone (20 nM), sodium selenate
(30 nM), and putrescine (60 μM), with equilibration
buffer supplemented with 4% fetal bovine serum. The
dish was attached to a pre-heated microscope stage
and incubated at 37°C in 5% CO2. Imaging was carried
out with an epifluorescence microscope from Keyence
(BZ9000) or a confocal Carl Zeiss microscope (LSM5
PASCAL Exciter). Images were acquired with a 10×
objective lens every 10 or 20 minutes, and processed
using the Keyence Bz-II application and Zeiss LSM5
software, respectively. NIH ImageJ 1.44e and Quick-
time Pro 7.6.8 were used for preparing movie files.
Spinal cord injury model
Adult female Sox10-V e n u sm i c e( 8 - w e e k so l d ,n=4f o r
each time point) were anesthetized with an intraperitoneal
injection of ketamine (100 mg/kg) and xylazine (10 mg/kg).
The dorsal surface of the dura mater was exposed after
laminectomy at the tenth thoracic vertebra, and SCI was
induced using an IH (Infinite Horizon) impactor (60 kDyn;
Precision Systems & Instrumentation) as described pre-
v i o u s l y[ 4 6 , 4 7 ] .T h em i c ew e r er e t u r n e dt ot h e i rh o m e
cages with free access to water and food. Intact mice and
mice at 4 and 14 days post-injury (dpi) were deeply
anesthetized and transcardially perfused with chilled PBS
followed by 4% paraformaldehyde (PFA). The spinal cords
were removed and immersed in 4% PFA at 4°C overnight,
and then immersed in 15% and 30% sucrose for 24 hours
each, at 4°C. The spinal cords were then embedded in
OCT compound and sectioned into 12-µm-thick sagittal
sections by cryostat (Leica CM3000).
Additional material
Additional file 1: Embryonic age-dependent fluorescence changes
compared among the Sox10-Venus, P0-Cre/CAG-CAT-EGFP, and
Wnt1-Cre/CAG-CAT-EGFP mouse strain. (A-C) Venus fluorescence
changes over time were observed from outside of the Sox10-Venus
embryo. Deep-tissue fluorescence gradually decreased from E11.5 d to
E15.5 d (see Figure 1 for additional photos). (C-E) At E14.5 d, reporter
gene expression patterns were quite similar between the transgenic
Sox10-Venus mouse and the double-transgenic mice P0-Cre/CAG-CAT-
EGFP and Wnt1-Cre/CAG-CAT-EGFP. Scale bars (A-E) 1.0 mm.
Additional file 2: Live imaging of single-cell movement: Sox10-
Venus
+ NC-derivatives in the superficial embryonic skin layer (1).
Time-lapse imaging with an epifluorescence microscope (Keyence)
showed Venus-positive cell movements in E14.5 d Sox10-Venus embryo
ex-vivo skin explants. One frame was captured every 10 minutes over a
6-hour period (motion: 6 fps).
Additional file 3: Live imaging of single-cell movement: Sox10-
Venus
+ neural crest derivatives in the superficial embryonic skin
layer (2). Confocal time-lapse imaging of the front facial area of the
whole E10.5 d Sox10-Venus embryo captured isolated Venus-positive
cells. The distinctive, intense Venus fluorescence made it possible to
follow migrating cells within the embryo over several hours, even
capturing the dynamic changes in cell shape. One frame was captured
every 20 minutes using a confocal Pascal microscope (Carl Zeiss). Scale
bar: 50 µm, motion: 4 fps.
Additional file 4: NC progeny were permanently EGFP-labeled in
the Wnt1-Cre/CAG-CAT-EGFP mouse. (A-B) Immunohistochemical
analysis with anti-GFP and marker antibodies for specific cell types
showed that the EGFP reporter gene is continuously expressed in NC
derivatives in the DRG (A) and sympathetic ganglia (B) of E15.5 d Wnt1-
Cre/CAG-CAT-EGFP mice. Scale bars (A-B) 50 μm.
Additional file 5: Table S1: Detailed information about sequences
and antibodies.
Abbreviations
NC: neural crest; OPC: oligodendrocyte progenitor cell; HMG: high mobility
group; PNS: peripheral nervous system; CNS: central nervous system; P0:
protein zero; EGFP: enhanced green fluorescent protein; CNP: 2’-3’-cyclic
nucleotide 3’-phosphodiesterase; PLP: myelin proteolipid protein; TH: tyrosine
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